Evaluation of the Sensitivity of Breast Cancer Cell Lines to Cardiac Glycosides Unveils ATP1B3 as a Possible Biomarker for the Personalized Treatment of ERα Expressing Breast Cancers

The molecular classification of breast cancer (BC) dictates pharmacological treatment. Estrogen receptor α (ERα) expressing tumors are treated with 4OH-tamoxifen or fulvestrant, which inhibits the receptor, or with aromatase inhibitors (i.e., anastrozole, letrozole, and exemestane) that reduce the 1...

Descripción completa

Detalles Bibliográficos
Autor principal: Acconcia, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569938/
https://www.ncbi.nlm.nih.gov/pubmed/36232400
http://dx.doi.org/10.3390/ijms231911102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569938/
https://www.ncbi.nlm.nih.gov/pubmed/36232400
http://dx.doi.org/10.3390/ijms231911102

Ejemplares similares